Related Experiment Videos

[Adjuvant treatment of cancers of the stomach]

¹Service d'Hépato-Gastroentérologie, Hôpital Général, Dijon.

Gastroenterologie Clinique Et Biologique

|January 1, 1994

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Geriatric analysis from PRODIGE 20 randomized phase II trial evaluating bevacizumab + chemotherapy versus chemotherapy alone in older patients with untreated metastatic colorectal cancer.

European journal of cancer (Oxford, England : 1990)·2018

Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08).

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Bevacizumab+chemotherapy versus chemotherapy alone in elderly patients with untreated metastatic colorectal cancer: a randomized phase II trial-PRODIGE 20 study results.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer.

European journal of cancer (Oxford, England : 1990)·2017

Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone.

The British journal of surgery·2015

See all related articles